Federal Register: October 28, 2009 (Volume 74, Number 207)
DOCID: fr28oc09-120 FR Doc E9-25894
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
NOTICE: NOTICES
DOCID: fr28oc09-120
SUBJECT CATEGORY:
Manufacturer of Controlled Substances; Notice of Registration
DOCUMENT SUMMARY:
By Notice dated June 22, 2009, and published in the Federal
Register on June 30, 2009, (74 FR 31314), Chattem Chemicals Inc., 3801
St. Elmo Avenue, Building 18, Chattanooga, Tennessee 37409, made
application by renewal to the Drug Enforcement Administration (DEA) to
be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II:
Drug Schedule 4Methoxyamphetamine (7411)................ I
Dihydromorphine (9145)..................... I
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Lisdexamfetamine (1205).................... II
Methylphenidate (1724)..................... II
Pentobarbital (2270)....................... II
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Hydrocodone (9193)......................... II
Meperidine (9230).......................... II
Morphine (9300)............................ II
Oripavine (9330)........................... II
Thebaine (9333)............................ II
Oxymorphone (9652)......................... II
Noroxymorphone (9668)...................... II
Alfentanil (9737).......................... II
Remifentanil (9739)........................ II
Sufentanil (9740).......................... II
Fentanyl (9801)............................ II
The company plans to manufacture the listed controlled substances in bulk for distribution to its customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Chattem Chemicals Inc. to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated Chattem Chemicals Inc. to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance with state and local laws, and a review of the
[[Page 55591]]
company's background and history. Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33, the above named company is
granted registration as a bulk manufacturer of the basic classes of controlled substances listed.
Dated: October 20, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. E925894 Filed 102709; 8:45 am]
BILLING CODE 441009P
SUMMARY:
Manufacturer of Controlled Substances; Registrations
DOCUMENT BODY 2:
By Notice dated June 22, 2009, and published in the Federal
Register on June 30, 2009, (74 FR 31314), Chattem Chemicals Inc., 3801
St. Elmo Avenue, Building 18, Chattanooga, Tennessee 37409, made
application by renewal to the Drug Enforcement Administration (DEA) to
be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II:
Drug Schedule 4Methoxyamphetamine (7411)................ I
Dihydromorphine (9145)..................... I
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Lisdexamfetamine (1205).................... II
Methylphenidate (1724)..................... II
Pentobarbital (2270)....................... II
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Hydrocodone (9193)......................... II
Meperidine (9230).......................... II
Morphine (9300)............................ II
Oripavine (9330)........................... II
Thebaine (9333)............................ II
Oxymorphone (9652)......................... II
Noroxymorphone (9668)...................... II
Alfentanil (9737).......................... II
Remifentanil (9739)........................ II
Sufentanil (9740).......................... II
Fentanyl (9801)............................ II
The company plans to manufacture the listed controlled substances in bulk for distribution to its customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Chattem Chemicals Inc. to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated Chattem Chemicals Inc. to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance with state and local laws, and a review of the
[[Page 55591]]
company's background and history. Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33, the above named company is
granted registration as a bulk manufacturer of the basic classes of controlled substances listed.
Dated: October 20, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. E925894 Filed 102709; 8:45 am]
BILLING CODE 441009P